• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Affluent Medical’s Artus artificial urinary sphincter successfully implanted in first-in-human pilot study

, 10 April 2024/in E-News /by panglobal

Affluent Medical, a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, has carried out a successful first-in-human implantation of the minimally invasive medical device Artus for the treatment of urinary incontinence as part of the European pilot study ‘Dry’.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/artus.jpg 1104 1666 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 11:57:172024-04-10 11:57:17Affluent Medical’s Artus artificial urinary sphincter successfully implanted in first-in-human pilot study

Ultrahuman raises $35 million to accelerate health monitoring wearables R&D

, 10 April 2024/in E-News /by panglobal

Ultrahuman, a pioneer in wearable tech, has raised $35 million in equity and debt investment. The series B funding round saw participation from venture capital firms Blume, Steadview, Nexus, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will use the funds to build more manufacturing capacity and expand research in the health tracking space.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/Ultrahuman_ring.png 2160 3840 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 11:54:132024-04-10 11:54:13Ultrahuman raises $35 million to accelerate health monitoring wearables R&D

Consortium kickstarts NextGen initiative for personalised CVD

, 10 April 2024/in E-News /by panglobal

An innovative project using artificial intelligence (AI) to personalise therapies for patients with cardiovascular disease has begun following a meeting in February in Utrecht, the Netherlands.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/Scherm­afbeelding-2024-04-10-om-13.49.35.png 720 668 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 11:50:172024-04-10 11:50:17Consortium kickstarts NextGen initiative for personalised CVD

Pioneering ultrasound research could prevent complications from neck surgery

, 10 April 2024/in E-News /by panglobal

Researchers in France have embarked on a four-year project to test the new non-invasive technique, that could help surgeons quickly and accurately assess patients for potentially life-changing complications after neck surgery. The research could have global relevance.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/neck_surgery_1.png 2048 2908 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 11:44:562024-04-10 11:44:56Pioneering ultrasound research could prevent complications from neck surgery

Prosthetics manufacturer WillowWood acquires socket manufacturer Xtremity

, 10 April 2024/in E-News /by panglobal

WillowWood Global, a leading designer, manufacturer, and distributor of prosthtic products, has acquired Xtremity. The transaction builds on WillowWood’s growing strength in custom solutions which includes central fabrication, design liners, and now fully adjustable prosthetic sockets.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/willowwood.jpg 1312 2360 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 10:31:142024-04-10 10:31:14Prosthetics manufacturer WillowWood acquires socket manufacturer Xtremity

WebMD reintroduces TINYpulse brand name for its Employee Engagement Solution

, 10 April 2024/in E-News /by panglobal

WebMD Health Services has reintroduced the ‘TINYpulse’ brand, continuing its commitment to advance tools and insights that help organizations create the ultimate culture of employee engagement and well-being, while delivering a solution that clients know and trust.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/Scherm­afbeelding-2024-04-10-om-12.28.36.png 860 1108 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 10:29:242024-04-10 10:29:24WebMD reintroduces TINYpulse brand name for its Employee Engagement Solution

DeepHealth and Incepto announce strategic partnership to expand access to AI-powered medical imaging

, 1 March 2024/in E-News /by panglobal

DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto, Europe’s leading platform for artificial intelligence (AI) solutions applied to medical imaging, announced they are partnering to deliver expanded access to DeepHealth clinical AI and radiology informatics software. The announcement took place at the European Congress of Radiology (ECR 2024) in […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/03/DeepHealth.jpg 844 1500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-03-01 09:24:072024-03-01 09:24:07DeepHealth and Incepto announce strategic partnership to expand access to AI-powered medical imaging

Discovery Park Ventures invests £100K in Vox Imaging Technology to advance ophthalmic imaging for preclinical research

, 8 February 2024/in E-News /by panglobal

Discovery Park Ventures (DPV) has invested £100K into Vox Imaging Technology (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/02/vox.jpg 940 1274 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-02-08 11:07:172024-02-08 11:07:17Discovery Park Ventures invests £100K in Vox Imaging Technology to advance ophthalmic imaging for preclinical research

TÜV SÜD designated as UKAB for active implantable medical devices

, 8 February 2024/in E-News /by panglobal

TÜV SÜD BABT Unlimited is now a designated UK Approved Body (UKAB) for Part III of the UK Medical Devices Regulations 2002 (SI 618, as amended) for Active Implantable Medical Devices. It is the first UKAB to achieve a designation scope for active implantable medical devices after progressing through the full initial designation application process. […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/02/TUVSUD-scaled.jpg 1708 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-02-08 11:04:382024-02-08 11:04:38TÜV SÜD designated as UKAB for active implantable medical devices

KARL STORZ acquires British AI 3D model specialist Innersight Labs

, 8 February 2024/in E-News /by panglobal

The family-owned MedTech company KARL STORZ has acquired the software manufacturer Innersight Labs (ISL), headquartered in London. ISL has developed software to enable surgeons to create patient-specific 3D models from CT or MRI scans.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/02/KARL-STORZ_ISL-scaled.jpg 1920 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-02-08 11:01:262024-02-08 11:01:54KARL STORZ acquires British AI 3D model specialist Innersight Labs
Page 22 of 231«‹2021222324›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription